NEOADJUVANT IMMUNOTHERAPY

Clinical trials for NEOADJUVANT IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for NEOADJUVANT IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Not yet finished but already full! 1

New drug duo tested to shrink tough kidney cancers before surgery

Disease control Recruiting now

This study is testing whether giving two newer cancer drugs together before surgery can help people with a specific type of high-risk upper tract bladder cancer. The drugs, tislelizumab and disitamab vedotin, aim to shrink the tumor and improve surgical outcomes, especially for p…

Matched conditions: NEOADJUVANT IMMUNOTHERAPY

Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control

Last updated Mar 09, 2026 14:25 UTC

NEOADJUVANT IMMUNOTHERAPY

Get alerted when new NEOADJUVANT IMMUNOTHERAPY trials appear

New drug duo tested to shrink tough kidney cancers before surgery